HK1256754B - Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use - Google Patents

Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use Download PDF

Info

Publication number
HK1256754B
HK1256754B HK18115834.8A HK18115834A HK1256754B HK 1256754 B HK1256754 B HK 1256754B HK 18115834 A HK18115834 A HK 18115834A HK 1256754 B HK1256754 B HK 1256754B
Authority
HK
Hong Kong
Prior art keywords
group
alkyl
formula
reaction
cryptophycin
Prior art date
Application number
HK18115834.8A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1256754A1 (en
Inventor
Antony Bigot
Hervé Bouchard
Marie-Priscille Brun
François CLERC
Jidong Zhang
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HK1256754A1 publication Critical patent/HK1256754A1/en
Publication of HK1256754B publication Critical patent/HK1256754B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Bedding Items (AREA)
HK18115834.8A 2015-11-05 2016-11-03 Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use HK1256754B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306751.7 2015-11-05
EP15306751 2015-11-05
PCT/EP2016/076603 WO2017076998A1 (en) 2015-11-05 2016-11-03 Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use

Publications (2)

Publication Number Publication Date
HK1256754A1 HK1256754A1 (en) 2019-10-04
HK1256754B true HK1256754B (en) 2020-06-05

Family

ID=54476881

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115834.8A HK1256754B (en) 2015-11-05 2016-11-03 Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use

Country Status (35)

Country Link
US (2) US10941139B2 (OSRAM)
EP (1) EP3371179B1 (OSRAM)
JP (1) JP6929292B2 (OSRAM)
KR (1) KR102822076B1 (OSRAM)
CN (1) CN108349960B (OSRAM)
AR (1) AR106604A1 (OSRAM)
AU (1) AU2016347724B2 (OSRAM)
CA (1) CA3003085A1 (OSRAM)
CL (1) CL2018001210A1 (OSRAM)
CO (1) CO2018004581A2 (OSRAM)
CR (1) CR20180256A (OSRAM)
CY (1) CY1122441T1 (OSRAM)
DK (1) DK3371179T3 (OSRAM)
EA (1) EA035625B1 (OSRAM)
EC (1) ECSP18034035A (OSRAM)
ES (1) ES2755101T3 (OSRAM)
HK (1) HK1256754B (OSRAM)
HR (1) HRP20191729T1 (OSRAM)
HU (1) HUE046033T2 (OSRAM)
IL (1) IL259067B (OSRAM)
LT (1) LT3371179T (OSRAM)
MA (1) MA43160B1 (OSRAM)
MX (1) MX374535B (OSRAM)
MY (1) MY189448A (OSRAM)
PH (1) PH12018500852B1 (OSRAM)
PL (1) PL3371179T3 (OSRAM)
PT (1) PT3371179T (OSRAM)
RS (1) RS59498B1 (OSRAM)
SG (1) SG11201803181SA (OSRAM)
SI (1) SI3371179T1 (OSRAM)
TN (1) TN2018000131A1 (OSRAM)
TW (1) TWI714661B (OSRAM)
UY (1) UY36979A (OSRAM)
WO (1) WO2017076998A1 (OSRAM)
ZA (1) ZA201802322B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI714661B (zh) * 2015-11-05 2021-01-01 法商賽諾菲公司 新穎念珠藻素化合物及接合物、其製備與其治療用途
CN107043380A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN110831633A (zh) 2017-05-10 2020-02-21 赛诺菲 可用于治疗的肽类接头和念珠藻素缀合物及其制备
CN108107103B (zh) * 2017-12-14 2020-10-16 华中师范大学 谷氨酸受体的质谱探针及其在脑组织中的空间分布规律检测方法
EP3935042B1 (en) 2019-03-07 2024-08-28 NOBO Medicine Inc. Caspase inhibitors and methods of use thereof
CN114651000A (zh) 2019-09-30 2022-06-21 密歇根大学董事会 念珠藻素抗癌剂的生物催化合成
EP4046996A1 (en) 2021-02-19 2022-08-24 Universität Bielefeld Cryptophycin compounds and conjugates thereof
EP4482529A1 (en) 2022-02-22 2025-01-01 Araris Biotech AG Peptide linkers comprising two or more payloads
EP4495108A1 (en) 2023-07-17 2025-01-22 Basf Se 3-[2-(2-oxo-1,3-dioxolan-4-ylidene)ethoxy]propanoic acid derivatives as precursors of monomers in polymerisations
EP4495105A1 (en) 2023-07-17 2025-01-22 Basf Se 3-(4-hydroxybut-2-ynoxy)propanoic acid ester, amide and nitrile derivatives as corrosion protection agents
WO2025082990A1 (en) 2023-10-15 2025-04-24 Araris Biotech Ag Antibody-drug conjugates using two different types of topoisomerase i inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203016T1 (de) * 1993-12-21 2001-07-15 Univ Hawaii Cryptophycine
US20020128185A1 (en) * 1998-02-25 2002-09-12 Chuan Shih Pharmaceutical compounds
US7230101B1 (en) 2002-08-28 2007-06-12 Gpc Biotech, Inc. Synthesis of methotrexate-containing heterodimeric molecules
US20050175619A1 (en) 2004-02-05 2005-08-11 Robert Duffy Methods of producing antibody conjugates
WO2007127440A2 (en) 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
KR101528939B1 (ko) 2006-07-18 2015-06-15 사노피 암 치료를 위한 epha2에 대한 길항제 항체
FR2947269B1 (fr) * 2009-06-29 2013-01-18 Sanofi Aventis Nouveaux composes anticancereux
AR078470A1 (es) 2009-10-02 2011-11-09 Sanofi Aventis Anticuerpos que se unen especificamente al receptor epha2
TWI714661B (zh) * 2015-11-05 2021-01-01 法商賽諾菲公司 新穎念珠藻素化合物及接合物、其製備與其治療用途

Also Published As

Publication number Publication date
CR20180256A (es) 2018-08-13
EA035625B1 (ru) 2020-07-17
PH12018500852A1 (en) 2018-10-29
SG11201803181SA (en) 2018-05-30
AU2016347724B2 (en) 2021-04-01
LT3371179T (lt) 2019-11-11
EP3371179A1 (en) 2018-09-12
IL259067B (en) 2021-07-29
TWI714661B (zh) 2021-01-01
NZ741734A (en) 2023-10-27
CN108349960B (zh) 2022-05-27
PT3371179T (pt) 2019-11-18
AR106604A1 (es) 2018-01-31
MX2018005379A (es) 2018-09-05
IL259067A (en) 2018-06-28
MA43160B1 (fr) 2019-12-31
RS59498B1 (sr) 2019-12-31
AU2016347724A1 (en) 2018-05-10
KR102822076B1 (ko) 2025-06-18
ECSP18034035A (es) 2018-05-31
WO2017076998A1 (en) 2017-05-11
HUE046033T2 (hu) 2020-01-28
US10941139B2 (en) 2021-03-09
US20210163458A1 (en) 2021-06-03
TW201730164A (zh) 2017-09-01
US20190382391A1 (en) 2019-12-19
PL3371179T3 (pl) 2020-02-28
KR20180073678A (ko) 2018-07-02
EA201890898A1 (ru) 2018-10-31
CN108349960A (zh) 2018-07-31
SI3371179T1 (sl) 2019-11-29
HRP20191729T1 (hr) 2019-12-13
CA3003085A1 (en) 2017-05-11
PH12018500852B1 (en) 2021-08-11
EP3371179B1 (en) 2019-08-07
ES2755101T3 (es) 2020-04-21
DK3371179T3 (da) 2019-11-11
BR112018008490A2 (pt) 2019-02-12
MY189448A (en) 2022-02-14
ZA201802322B (en) 2019-01-30
CL2018001210A1 (es) 2018-08-17
MX374535B (es) 2025-03-06
JP2018535255A (ja) 2018-11-29
CO2018004581A2 (es) 2018-07-19
TN2018000131A1 (en) 2019-10-04
UY36979A (es) 2017-06-30
CY1122441T1 (el) 2021-01-27
JP6929292B2 (ja) 2021-09-01

Similar Documents

Publication Publication Date Title
EP3371179B1 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
HK1256754A1 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
AU2022204711C1 (en) Peptidic linkers and cryptophycin conjugates, useful in therapy, and their preparation
BR112018008490B1 (pt) Compostos e conjugados de criptoficina, processos para a preparação dos mesmos, medicamento e composição farmacêutica
EA045708B1 (ru) Новые пептидные линкеры и конъюгаты на основе криптофицина, их получение и их терапевтическое применение
NZ741734B2 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use